Shanghai Henlius Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	772.21	772.96	987.67	680.48	707.33
Short-Term Investments	71.04	40.77	21.7	31.4	34.99
Cash & Short-Term Investments	843.25	813.73	1,009	711.87	742.32
Cash Growth	3.63%	-19.38%	41.79%	-4.10%	-34.79%
Accounts Receivable	1,833	901.36	730.25	455.51	295.74
Other Receivables	-	-	-	160.19	-
Receivables	1,833	901.36	730.25	615.7	295.74
Inventory	612.41	728.27	757.36	757.31	420.11
Other Current Assets	197.11	68.17	179.07	106.66	188.99
Total Current Assets	3,486	2,512	2,676	2,192	1,647
Property, Plant & Equipment	2,581	2,700	2,653	2,230	1,667
Other Intangible Assets	3,527	3,696	3,261	2,703	1,919
Long-Term Deferred Tax Assets	71.52	-	-	-	-
Long-Term Deferred Charges	2,636	1,659	1,250	1,629	1,716
Other Long-Term Assets	59.81	30.34	64.16	170.61	223.67
Total Assets	12,361	10,598	9,904	8,924	7,173
Accounts Payable	831.01	729.1	544.82	713.55	383.47
Accrued Expenses	1,051	1,037	975.85	832.73	417.78
Short-Term Debt	1,833	2,064	2,250	1,839	1,351
Current Portion of Long-Term Debt	355.64	430.62	463.58	601.62	145.64
Current Portion of Leases	58.14	64.98	86.96	81.45	74.19
Current Income Taxes Payable	51.17	-	83.14	20.78	21.64
Current Unearned Revenue	518.12	444.03	466.88	322.42	138.3
Other Current Liabilities	242.78	262.06	196.37	589.94	427.86
Total Current Liabilities	4,941	5,032	5,067	5,002	2,960
Long-Term Debt	1,249	951.27	1,106	975.29	833.7
Long-Term Leases	101.74	137.4	186.46	179.65	218.56
Long-Term Unearned Revenue	1,921	1,314	1,179	839.09	809.68
Other Long-Term Liabilities	188.88	149.27	172.07	292.37	54.43
Total Liabilities	8,401	7,584	7,711	7,288	4,876
Common Stock	543.5	543.5	543.5	543.5	543.5
Additional Paid-In Capital	6,069	6,069	6,069	6,052	6,010
Retained Earnings	-2,277	-3,104	-3,924	-4,470	-3,775
Comprehensive Income & Other	-375.45	-495.26	-496.11	-488.43	-481.1
Total Common Equity	3,960	3,014	2,192	1,636	2,297
Shareholders' Equity	3,960	3,014	2,192	1,636	2,297
Total Liabilities & Equity	12,361	10,598	9,904	8,924	7,173
Total Debt	3,597	3,648	4,093	3,677	2,623
Net Cash (Debt)	-2,754	-2,834	-3,084	-2,965	-1,881
Net Cash Per Share	-5.04	-5.22	-5.68	-5.47	-3.49
Filing Date Shares Outstanding	543.49	543.49	543.49	543.49	543.49
Total Common Shares Outstanding	543.49	543.49	543.49	543.49	543.49
Working Capital	-1,455	-2,520	-2,391	-2,810	-1,313
Book Value Per Share	7.29	5.54	4.03	3.01	4.23
Tangible Book Value	433.78	-682.42	-1,068	-1,067	377.41
Tangible Book Value Per Share	0.80	-1.26	-1.97	-1.96	0.69
Buildings	1,164	767.01	629.26	-12,931	-
Machinery	1,486	1,417	1,047	11,358	859.43
Construction In Progress	216.48	584.24	816.16	1,003	399.69
Leasehold Improvements	369.26	360.25	346.79	2,840	295.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.